Impact of the 13-Valent Pneumococcal Conjugate Vaccine on the Incidence of All-cause Pneumonia in Adults Aged ≥60 Years: A Population-based, Retrospective Cohort Study
Abstract. In this population-based study evaluating the effectiveness of the 13-valent pneumococcal conjugate vaccine (2012–2016) to prevent all-cause pneumoni